Equities

Zhejiang Shengda Bio-Pharm Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Zhejiang Shengda Bio-Pharm Co Ltd

Actions
Consumer Staples Food Producers
  • Price (CNY)19.50
  • Today's Change-0.270 / -1.37%
  • Shares traded2.44m
  • 1 Year change+39.48%
  • Beta0.8142
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Zhejiang Shengda Bio-Pharm Co Ltd is a China-based company principally engaged in the research and development, production and sales of biotin and biological preservatives. The Company's main products include vitamin products such as biotin and folic acid, biological preservatives and functional ingredients such as nisin, natamycin, polylysine, and sucrose fermentation products. The Company's products are mainly used in feed additives, food additives, daily chemicals, pharmaceuticals and other fields. The Company mainly operates its businesses in the domestic and overseas markets.

  • Revenue in CNY (TTM)839.82m
  • Net income in CNY61.08m
  • Incorporated1999
  • Employees1.04k
  • Location
    Zhejiang Shengda Bio-Pharm Co LtdNo.789, Renmin East Road, Tiantai CountyTAIZHOU 317200ChinaCHN
  • Phone+86 57 683938598
  • Fax+86 57 683966111
  • Websitehttps://www.sd-pharm.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cabio Biotech Wuhan Co Ltd596.47m169.67m3.28bn565.0019.302.02--5.501.011.013.569.670.34211.982.801,055,705.009.517.0810.297.6048.8444.7327.8025.354.44--0.0634.5225.1912.2735.941.0055.50-10.87
Ganso Co Ltd1.96bn126.43m3.30bn4.67k26.142.13--1.690.52680.52688.176.470.583312.9510.21419,887.303.769.777.0016.4361.9861.136.4511.501.26--0.172283.84-12.990.8061-9.980.0796-3.32-3.58
Qingdao Richen Food Co Ltd451.39m73.74m3.43bn429.0045.684.52--7.610.76230.76234.697.710.43168.695.001,052,181.007.057.888.919.5737.0641.0816.3419.941.14149.190.243438.2912.597.2213.16-5.6294.73-14.59
Zhejiang Wufangzhai Industry Co Ltd2.19bn106.61m3.47bn3.57k32.991.97--1.590.53440.534411.288.950.898.1412.84613,913.404.348.025.7811.3535.2540.114.876.141.49--0.047444.62-14.57-2.13-14.24-2.7222.03--
Zhejiang Shengda Bio-pharm Co Ltd839.82m61.08m3.74bn1.04k56.932.37--4.450.34730.34734.778.340.43223.195.42811,416.803.533.244.064.0924.1726.028.176.973.51--0.160237.2513.759.77154.43-8.95-1.79--
Solbar Ningbo Protein Technology Co Ltd1.64bn176.19m3.80bn756.0021.581.94--2.320.92020.92028.5710.260.78015.9311.312,170,059.008.38--9.15--16.56--10.74--5.43--0.0123---11.04---16.99------
Suzhou Weizhixiang Food Co Ltd692.19m72.70m3.95bn403.0052.893.19--5.710.54170.54175.138.980.514615.3137.831,717,605.005.4112.085.9812.9721.3525.8910.5017.065.57--0.0052.14-15.904.38-35.360.2963-2.68--
Apple Flavor & Fragrance Group Co Ltd2.47bn182.26m4.23bn927.0022.731.28--1.710.48520.48526.588.630.65043.926.962,666,800.005.594.966.425.9815.5715.388.595.9010.37--0.004132.26-3.581.6375.250.9421-3.733.71
Data as of Feb 11 2026. Currency figures normalised to Zhejiang Shengda Bio-Pharm Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

1.36%Per cent of shares held by top holders
HolderShares% Held
CITIC-Prudential Fund Management Co., Ltd.as of 30 Jun 2025695.00k1.06%
Baoying Fund Management Co., Ltd.as of 30 Jun 202583.00k0.13%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 202549.30k0.08%
Bosera Asset Management Co., Ltd.as of 30 Jun 202535.00k0.05%
Wanjia Asset Management Co., Ltd.as of 30 Jun 202515.20k0.02%
Zhejiang Zheshang Securities Asset Management Co., Ltd.as of 30 Jun 20258.80k0.01%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 20252.20k0.00%
Orient Fund Management Co., Ltd.as of 30 Jun 2025600.000.00%
Broad Fund Management Co. Ltd.as of 30 Jun 2025100.000.00%
Western Leadbank Fund Management Co., Ltdas of 30 Jun 20250.000.00%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.